Entering text into the input field will update the search result below

PhaseBio Pharmaceuticals EPS misses by $0.05, misses on revenue

  • PhaseBio Pharmaceuticals (NASDAQ:PHAS): Q3 GAAP EPS of -$0.66 misses by $0.05.
  • Revenue of $0.34M misses by $0.73M.
  • Press Release

Recommended For You

About PHASQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PHASQ--
PhaseBio Pharmaceuticals, Inc.